相关实验视频
Updated: May 1, 2026

10:08
Pseudofracture: An Acute Peripheral Tissue Trauma Model
Published on: April 18, 2011
14.7K
在多创伤患者中早期死亡率的实际预测模型的开发和验证:来自瑞士的二次分析
Yongzhuang Chen1, Xianjie Wei2, Xiaoyun Sun3
1Department of Anesthesiology, Yancheng No.1 People's Hospital, Yancheng, Jiangsu, People's Republic of China.
BMJ open
|June 12, 2025
概括
开发了一种用于多创伤患者死亡率的新预测工具,使用年龄,格拉斯哥昏迷量表 (GCS),基数过量 (BE) 和血清乳酸. 这个模型准确地预测了早期死亡,乳酸是关键因素.
科学领域:
- 创伤外科 手术 创伤外科
- 关键护理医学 关键护理医学
- 紧急医疗 紧急医疗
背景情况:
- 多创伤在预测患者死亡率方面存在重大挑战.
- 现有的评分系统可能无法充分捕捉多创伤中早期死亡的复杂性.
研究的目的:
- 开发和验证多创伤患者早期死亡率的实用预测工具.
- 在这个患者群体中确定早期死亡的关键预测因素.
主要方法:
- 对包括2406名多创伤患者在内的公共数据库的二次分析.
- 后勤回归被用来识别早期死亡率的独立预测因素.
- 通过歧视,校准和决策曲线分析构建和验证了一个名ogram模型.
主要成果:
- 早期死亡的独立预测因素包括年龄,格拉斯哥昏迷表 (GCS),基过量 (BE) 和血清乳酸.
- 开发的诺米图表显示出强大的预测性能 (AUC = 0.85),优于现有的创伤得分.
- 血清乳酸被确定为早期死亡的一个特别重要的因素.
结论:
- 已经建立了一个简单且易于使用的多创伤患者早期死亡预测模型.
- 该模型结合了易于获得的入院参数:年龄,GCS,BE和血清乳酸.
- 这种工具可以帮助临床医生对多创伤患者的风险分层和管理.
相关概念视频
Introduction To Survival Analysis
955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
955
Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Kaplan-Meier Approach
792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Assumptions of Survival Analysis
492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

